Olema Pharmaceuticals, Inc. (OLMA) Institutional Ownership

Ownership Summary

The institutional landscape for Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) includes 4 filers as of the latest reporting cycle ending December 2025.

• The collective stake of institutional investors in Olema Pharmaceuticals moved to 0.1% in December 2025, a shift down from the 80.3% reported for September 2025.
• The company experienced a 4060.00% quarterly change in institutional shares held, alongside a decrease of 97.45% in total owners annually.
• During the quarter, 2 institutions bought more Olema Pharmaceuticals shares, 1 sold shares, and 1 of the 4 total investors held their position steady.
• The total number of shares held by institutions in Olema Pharmaceuticals increased to 71.34K as of December 2025, a net change of up by 69.63K shares quarter on quarter, and down 71.24Mn shares year over year.
• SG Americas Securities, LLC's holding of 69.38K shares as of December 31, 2025 makes it the primary institutional investor in Olema Pharmaceuticals, owning 0.08% of the stock.
• Among the most significant buyers of Olema Pharmaceuticals during December 2025 were SG Americas Securities, LLC (69.38K), GAMMA Investing LLC (492).
• Leading sellers of Olema Pharmaceuticals stock in December 2025 included Versant Capital Management, Inc (245).
• The top 4 institutional holders of Olema Pharmaceuticals for the quarter ending December 2025 included SG Americas Securities, LLC (69.38K), Versant Capital Management, Inc (1.18K), GAMMA Investing LLC (723), True Wealth Design, LLC (61).